COMMUNIQUÉS West-GlobeNewswire

Qrons Appoints Veteran U.S. Based Biotech Executive Dr. John N. Bonfiglio to Lead IND and Capital Markets Related Activities
27/06/2019
New York, NY, June 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Qrons Inc. (OTC: QRON), an emerging biotechnology company developing advanced stem cell-synthetic hydrogel-based solutions for the treatment of [...]
Chicago-based Psychiatrist, Dr. Fabian Carbonell, Debuts Innovative FDA-Cleared Treatment for Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD)
27/06/2019
Dr. Carbonell joins practices around the country that have adopted BrainsWay’s revolutionary Deep Transcranial Magnetic Stimulation (Deep TMS) therapy for MDD and OCD, providing patients in the Chicago area access to [...]
Kannalife, Inc. to Present Breakthrough CIPN Study Findings on the Comparison of KLS-13019 to CBD at 29th Annual International Cannabinoid Research Society Conference
27/06/2019
DOYLESTOWN, Pa., June 27, 2019 (GLOBE NEWSWIRE) -- Kannalife, Inc. (OTC: KLFE) (“Kannalife” or “the Company”), a biopharmaceutical company focused on the research, development and discovery of natural and novel [...]
Alphatec Announces Organizational and Corporate Updates
27/06/2019
Appointment of Karen McGinnis to Board of Directors Inclusion in Russell 2000 ® Index Drawdown on Squadron Credit Facility CARLSBAD, Calif., June 27, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “ [...]
OLAH Healthcare Technology welcomes Max Immelman as Senior Sales Executive
27/06/2019
COLUMBUS, Ohio, June 27, 2019 (GLOBE NEWSWIRE) -- Max Immelman recently joined OLAH Healthcare Technology as Senior Sales Executive. With more than 18 years of experience in healthcare information technology, Immelman [...]
RenovaCare Appoints VP to Expand and Accelerate Intellectual Property and Licensing
27/06/2019
SCOTTSDALE, Ariz., June 27, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc., (Symbol: RCAR; www.renovacareinc.com ), developer of the SkinGun™ and other patented technologies for spraying a patient’s own stem cells onto burns [...]
Zenith Epigenetics Announces Dosing of First Patient in Triple Negative Breast Cancer Trial with Pfizer
27/06/2019
CALGARY, Alberta, June 27, 2019 (GLOBE NEWSWIRE) -- Zenith Epigenetics Ltd. (“Zenith” or the “Company”), a wholly-owned subsidiary of Zenith Capital Corp., announced today that it has dosed the first patient in a Phase [...]
Spring Bank to Present Pre-Clinical Data on Its Novel STING Antagonist Program at The Autoimmunity Conference
27/06/2019
HOPKINTON, Mass., June 27, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]
Evoke Pharma Requests Type A FDA Meeting to Plan for Resubmission of Gimoti™ NDA
27/06/2019
SOLANA BEACH, Calif., June 27, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it has [...]
Hemostemix Announces Enrollment Update for the ACP-01 Phase II Critical Limb Ischemia Clinical Trial
27/06/2019
CALGARY, Alberta, June 27, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to announce that it has enrolled a total of forty (40) patients in its [...]
REPEAT - AgraFlora Organics Provides Licensing Guidance and Operational Updates at GMP-Certified GTA Bottling Facility
27/06/2019
VANCOUVER, British Columbia, June 27, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF ), a growth oriented and diversified [...]
Dova Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application for DOPTELET® (avatrombopag) for Treatment of Chronic Immune Thrombocytopenia (ITP)
27/06/2019
Company Strengthens Thrombocytopenia Portfolio with ITP Approval and Expanded Partnership with Salix for Chronic Liver Disease (CLD) Indication Company to Host Conference Call at 9am EST DURHAM, N.C., June 27, 2019 ( [...]
ContraVir Pharmaceuticals Submits IND Application for CRV431 for NASH
27/06/2019
IND positions NASH as a second indication for CRV431, in addition to HBV EDISON, N.J., June 27, 2019 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the [...]
SI-BONE’s iFuse Implant System Surpasses 40,000 Procedures
27/06/2019
Long-term prospective study with 5-year follow-up submitted for publication SANTA CLARA, Calif., June 27, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to [...]
Adrian Rawcliffe to Succeed James Noble as Adaptimmune Chief Executive Officer
27/06/2019
James Noble will transition to become a Non-Executive Director PHILADELPHIA and OXFORDSHIRE, United Kingdom, June 27, 2019 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP) today announced that Adrian [...]
SunGen Pharma Announces to Partner with Athenex Pharmaceutical to Launch Bivalirudin through PIV Challenges in US
27/06/2019
PRINCETON, N.J., June 27, 2019 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced to [...]
Ovid Therapeutics Initiates Pivotal Phase 3 Clinical Trial in Angelman Syndrome; Multiple Data Readouts Across Rare Neurological Disease Pipeline Expected in 2H 2019 and Early 2020
27/06/2019
Phase 3 NEPTUNE Trial of OV101 Expected to Enroll the First Patients in the Third Quarter of 2019; CGI-I Angelman Syndrome Scale will be the Sole Primary Endpoint Ovid to Review NEPTUNE Trial Details and Additional [...]
Wave Life Sciences Announces Initiation of DYSTANCE 51, a Phase 2/3 Clinical Trial of Suvodirsen
27/06/2019
Global study designed to assess the efficacy and safety of suvodirsen in DMD patients amenable to exon 51 skipping Results intended to support regulatory approvals globally CAMBRIDGE, Mass., June 27, 2019 (GLOBE [...]
Entasis Therapeutics Announces New Results Supporting Advancement of Multiple Pathogen-Targeted Antimicrobial Programs at ASM Microbe 2019
27/06/2019
WALTHAM, Mass., June 27, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, [...]

Pages